• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[The role of allogeneic hematopoietic stem cell transplant in therapy of chronic myeloid leukemia in the era of tyrosine kinase inhibitors].

作者信息

Liang Yingmin

机构信息

Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):92-3. doi: 10.3760/cma.j.issn.0253-2727.2014.02.002.

DOI:10.3760/cma.j.issn.0253-2727.2014.02.002
PMID:24606641
Abstract
摘要

相似文献

1
[The role of allogeneic hematopoietic stem cell transplant in therapy of chronic myeloid leukemia in the era of tyrosine kinase inhibitors].
Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):92-3. doi: 10.3760/cma.j.issn.0253-2727.2014.02.002.
2
[The effect of tyrosine kinase inhibitor on outcome of allogeneic hematopoietic stem cell transplant for the treatment of chronic myeloid leukaemia].酪氨酸激酶抑制剂对异基因造血干细胞移植治疗慢性髓性白血病疗效的影响
Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):94-5. doi: 10.3760/cma.j.issn.0253-2727.2014.02.003.
3
TKIs and transplant for chronic myeloid leukemia.酪氨酸激酶抑制剂与慢性髓性白血病的移植治疗
Leuk Res. 2010 Feb;34(2):137-8. doi: 10.1016/j.leukres.2009.07.018. Epub 2009 Aug 3.
4
Allogeneic hematopoietic stem cell transplantation for the treatment of chronic myeloid leukemia in the era of tyrosine kinase inhibitors.酪氨酸激酶抑制剂时代异基因造血干细胞移植治疗慢性髓系白血病
Chin Med J (Engl). 2013 Feb;126(4):768-74.
5
Who with chronic myelogenous leukemia to transplant in the era of tyrosine kinase inhibitors?在酪氨酸激酶抑制剂时代，慢性髓性白血病患者适合进行移植吗？
Curr Opin Hematol. 2008 Mar;15(2):127-33. doi: 10.1097/MOH.0b013e3282f428ac.
6
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后慢性期和晚期复发的慢性髓性白血病患者对酪氨酸激酶抑制剂治疗的反应。
Biol Blood Marrow Transplant. 2010 May;16(5):639-46. doi: 10.1016/j.bbmt.2009.11.026. Epub 2010 Feb 4.
7
Tyrosine kinase inhibitors and allogeneic hematopoietic cell transplantation for chronic myeloid leukemia: targeting both therapeutic modalities.酪氨酸激酶抑制剂与异基因造血细胞移植治疗慢性髓性白血病：针对两种治疗方式
Cancer Control. 2009 Apr;16(2):153-7. doi: 10.1177/107327480901600207.
8
Recent advancements in the treatment of chronic myelogenous leukemia.慢性粒细胞白血病治疗的最新进展
Annu Rev Med. 2002;53:369-81. doi: 10.1146/annurev.med.53.082901.103853.
9
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.酪氨酸激酶抑制剂治疗时代异基因 SCT 治疗慢性髓性白血病患者的结局。
Ann Hematol. 2013 Apr;92(4):487-96. doi: 10.1007/s00277-012-1650-8. Epub 2012 Dec 19.
10
[Treatment of acute leukemias and chronic myeloid leukemias].[急性白血病和慢性髓性白血病的治疗]
Soins. 2008 Mar(723):44-5.